Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation
NCT06575530Phase 4Recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- Jan 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in sedation, sponsored by Beijing Shijitan Hospital. Started Jan 2025; status: recruiting.
02
Drugs
remimazolam
03
Conditions
sedation
Beyond the preview
Go deeper on NCT06575530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06575530.